Related Experiment Video

Updated: Jul 17, 2026

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder
04:33

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Published on: April 26, 2024

Effects of antidepressant treatment on cognitive performance in elderly subjects with heart failure and comorbid

Tânia C T F Alves1, Jairo Rays, Renata M S Telles

  • 1Department of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil. tania_alves@hotmail.com

Psychosomatics
|January 9, 2007
PubMed

Insights

Heart failure (HF) patients often experience cognitive deficits, which may worsen with major depressive disorder (MDD). Antidepressant treatment improved cognition in depressed HF patients, highlighting the importance of managing MDD in HF.

Area of Science:

  • Cardiology
  • Neurology
  • Psychiatry

Background:

  • Cognitive deficits are frequently observed in patients with heart failure (HF).
  • The co-occurrence of major depressive disorder (MDD) may exacerbate cognitive impairment in HF patients.
  • Understanding the interplay between HF, MDD, and cognition is crucial for comprehensive patient care.

Purpose of the Study:

  • To compare cognitive performance in heart failure patients with and without major depressive disorder against healthy controls.
  • To evaluate the impact of antidepressant treatment on cognitive function in heart failure patients with comorbid major depressive disorder.

Main Methods:

  • Utilized the Cambridge Mental Disorders of the Elderly Examination (CAMCOG) battery.
  • Compared cognitive performance across three groups: MDD-HF (N=20), non-depressed HF (N=23), and healthy controls (N=18).
  • Assessed cognitive changes following antidepressant treatment in the MDD-HF group.

Main Results:

  • Both heart failure groups (MDD-HF and non-depressed HF) exhibited lower cognitive scores compared to healthy controls.
  • Significant improvements in cognitive performance were observed in the MDD-HF group after receiving antidepressant treatment.
  • Cognitive impairment is a notable issue in heart failure patients, irrespective of comorbid depression.

Conclusions:

  • Cognitive impairment is prevalent in heart failure patients, both with and without major depressive disorder.
  • Treating major depressive disorder symptoms in heart failure patients can lead to significant cognitive improvements.
  • Recognizing and managing comorbid major depressive disorder is essential for addressing cognitive deficits in heart failure.

More Related Videos

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...